| Roy R Clark, MD | |
|
8800 Barnes Lake Rd, Irwin, PA 15642-3177 | |
| (724) 832-9190 | |
| (724) 978-0544 |
| Full Name | Roy R Clark |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 8800 Barnes Lake Rd, Irwin, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215938907 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | MD055102L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Excela Health Westmoreland Regional Hospital | Greensburg, PA | Hospital |
| Forbes Hospital | Monroeville, PA | Hospital |
| Excela Health - Frick Hospital | Mount pleasant, PA | Hospital |
| Excela Health Latrobe Hospital | Latrobe, PA | Hospital |
| Uniontown Hospital | Uniontown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allegheny Clinic | 5395649586 | 1941 |
News Archive
As the COVID-19 pandemic enters a new phase, punctuated by emerging hot spots and continuing global spread, a new analytical tool developed by RAND Corporation researchers allows policymakers to predict regional risks of importing cases of COVID-19.
More than 68 percent of Americans 65 and older - 80 percent age 75 and over - have hypertension (high blood pressure), according to a 2010 report by the Centers for Disease Control. Left untreated, this chronic condition can lead to stroke, heart attack, heart failure or premature death. Researchers at UMDNJ-Robert Wood Johnson Medical School have shown in a follow-up to the landmark clinical trial, Systolic Hypertension in the Elderly Program (SHEP), that the use of antihypertensive drug therapy is associated with longer life expectancy.
The Neuroendocrine Tumor Research Foundation has announced a new round of scientific and clinical research grants, aimed at advancing the treatment of and the search for cures to neuroendocrine tumors.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
› Verified 9 days ago
| Entity Name | Adagio Health Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295826022 PECOS PAC ID: 3870488950 Enrollment ID: O20040310000249 |
News Archive
As the COVID-19 pandemic enters a new phase, punctuated by emerging hot spots and continuing global spread, a new analytical tool developed by RAND Corporation researchers allows policymakers to predict regional risks of importing cases of COVID-19.
More than 68 percent of Americans 65 and older - 80 percent age 75 and over - have hypertension (high blood pressure), according to a 2010 report by the Centers for Disease Control. Left untreated, this chronic condition can lead to stroke, heart attack, heart failure or premature death. Researchers at UMDNJ-Robert Wood Johnson Medical School have shown in a follow-up to the landmark clinical trial, Systolic Hypertension in the Elderly Program (SHEP), that the use of antihypertensive drug therapy is associated with longer life expectancy.
The Neuroendocrine Tumor Research Foundation has announced a new round of scientific and clinical research grants, aimed at advancing the treatment of and the search for cures to neuroendocrine tumors.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
› Verified 9 days ago
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
As the COVID-19 pandemic enters a new phase, punctuated by emerging hot spots and continuing global spread, a new analytical tool developed by RAND Corporation researchers allows policymakers to predict regional risks of importing cases of COVID-19.
More than 68 percent of Americans 65 and older - 80 percent age 75 and over - have hypertension (high blood pressure), according to a 2010 report by the Centers for Disease Control. Left untreated, this chronic condition can lead to stroke, heart attack, heart failure or premature death. Researchers at UMDNJ-Robert Wood Johnson Medical School have shown in a follow-up to the landmark clinical trial, Systolic Hypertension in the Elderly Program (SHEP), that the use of antihypertensive drug therapy is associated with longer life expectancy.
The Neuroendocrine Tumor Research Foundation has announced a new round of scientific and clinical research grants, aimed at advancing the treatment of and the search for cures to neuroendocrine tumors.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roy R Clark, MD 8800 Barnes Lake Rd, Irwin, PA 15642-3177 Ph: (724) 832-9190 | Roy R Clark, MD 8800 Barnes Lake Rd, Irwin, PA 15642-3177 Ph: (724) 832-9190 |
News Archive
As the COVID-19 pandemic enters a new phase, punctuated by emerging hot spots and continuing global spread, a new analytical tool developed by RAND Corporation researchers allows policymakers to predict regional risks of importing cases of COVID-19.
More than 68 percent of Americans 65 and older - 80 percent age 75 and over - have hypertension (high blood pressure), according to a 2010 report by the Centers for Disease Control. Left untreated, this chronic condition can lead to stroke, heart attack, heart failure or premature death. Researchers at UMDNJ-Robert Wood Johnson Medical School have shown in a follow-up to the landmark clinical trial, Systolic Hypertension in the Elderly Program (SHEP), that the use of antihypertensive drug therapy is associated with longer life expectancy.
The Neuroendocrine Tumor Research Foundation has announced a new round of scientific and clinical research grants, aimed at advancing the treatment of and the search for cures to neuroendocrine tumors.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
› Verified 9 days ago
Dr. Karim Khalil, Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 9173 Route 30, Irwin, PA 15642 Phone: 724-864-3550 Fax: 724-864-5005 | |
Megan Kathryn Wright, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8955 Lincoln Hwy E, Irwin, PA 15642 Phone: 866-866-4196 |